|
|
|
Quick Links
|
OhioChildren's Hospital Medical Center General Clinical Research Center Web site: www.cincinnatichildrens.org/gcrc Grant No. M01 RR08084 Special Assays, Services, or Tests Bone-specific alkaline phosphatase Nutrition services: Indirect calorimetry, anthropometry,
computerized dietary analysis Major Areas of InvestigationAllergy and Immunology: Allergen elimination diets and severity of asthma; effect of intravenous mepolizumab on the outcome and management of hypereosinophilic syndromes. Cardiology: Cardiovascular risk tracking study; blood pressure divergence in adolescent females; vitamin E intake and oxidized low-density lipoprotein; effect of pre-operative methylprednisolone on inflammatory response following cardiopulmonary bypass; body mass index rebound epidemiology; genetic epidemiology of energy metabolism; neurohormonal activation in single ventricular physiology. Critical Care Medicine: Adrenal dysfunction in children with septic shock; nitric oxide in infants with respiratory failure. Developmental Disorders: Human synthetic secretin in children with autism; effect of oral baclofen on function in cerebral palsy. Endocrinology: Glucagon-like peptide-1 in diabetic and nondiabetic humans, including effects on insulin secretion; mechanisms and implications of discordant hemoglobin A1c; rhIGF-1 in children with short stature and growth hormone insensitivity syndrome; coronary atherosclerosis in early insulin-dependent diabetes mellitus; sulfonylurea therapy in patients with mutations in the Delta F508 CF transmembrane conductance regulator gene; IGF-1 receptor mutations in human uterine growth retardation; effects of ketogenic diet on body weight/cardiovascular risk factors. Gastroenterology and Nutrition: Cholera challenge trial; bile acid therapy in treatment of childhood liver disease, including cystic fibrosis, total parenteral nutrition-related cholestasis, and peroxisomal diseases; inborn errors of bile acid metabolism; analysis and physiology of soy isoflavones; cholesterol supplementation and synthesis rates in infants; regulation of plasma cholesterol levels by cholesterol absorption, synthesis, and LDL-receptors; intranasal vitamin B12 dosing interval; rectal bleeding in infants; borderline pancreatic function assessment in cystic fibrosis; role of magnesium in pathogenesis of childhood cholestatic liver disease; reduced bone mass in nonambulatory children and adults; intravenous methylprednisolone versus oral prednisolone in treatment of acute rejection in liver transplant patients; effect of fat ingestion on serum apolipoprotein A-IV levels; pharmacokinetics of the supplement, secoisolariciresinol diglycoside. General Pediatrics: Melatonin metabolism studies looking at shift work and effects on blood pressure in type 1 diabetes; suckling and PTHrP secretion and renal activity; bone mass tracking studies; bone density and forearm fractures in injured children. Hematology: Sickle cell disease, including biotinylated erythrocyte studies and causes for thrombophilia. Hepatology: Response of hepatitis C virus to pegylated interferon and ribavirin in hemophilic patients with/without coinfection with HIV. Human Genetics: Phenotype and genetics of Gaucher's disease; enzyme therapy for Gaucher's disease; antiresorptive therapy for osteopenia in Gaucher's disease; bone densitometry in subjects with neurofibromatosis. Infectious Disease: Indinavir/ritonavir therapy in HIV-affected subjects; efavirenz/nelfinavir pharmacokinetic study; pharmacokinetic interactions between HIV protease inhibitors and calcium channel blockers. Neonatology: Hypothermia trial in term infants; parenteral glutamine supplementation in low-birthweight infants. Nephrology: Renal tubular function in Bartter syndrome; immunosuppressive therapy after renal transplant in children; treatment of childhood nephrotic syndrome; urea kinetic modeling in hemodialysis patients; vascular abnormalities in children and adolescents with chronic renal disease; normalization of hematocrit in patients with chronic renal disease. Psychiatry: Clomipramine treatment trials in depression and obsessive-compulsive disorder; fibromyalgia genetic studies. Psychology: Behavioral nutrition studies involving weight gain in cystic fibrosis, feeding preterm infants, increasing dietary calcium in juvenile rheumatoid arthritis, and young children with chronic illness and their families; neuropsychological functioning in adolescents with spina bifida; Children's Health and Natural Growth Evaluation Study; depression and nutrition in pediatric sickle cell disease. Pulmonary Medicine: Aerosolized tobramycin in young children with cystic fibrosis; dose cohort studies in cystic fibrosis subjects; effect of obstructive sleep apnea on cardiac function and structure in children. Rheumatology: Calcium supplementation for bone mineralization in juvenile rheumatoid arthritis; genetic juvenile rheumatoid arthritis studies. Contact InformationFor information about this GCRC and how to access its resources, please contact: Administrative Manager Program Director Principal Investigator Associate Program Director Associate Program Director Research Subject Advocate GCRC Advisory Committee Chairperson Nurse Manager Core Laboratory Director Nutrition Research Manager Biostatistician Ohio State University General Clinical Research Center Web Site: http://gcrc.osu.edu/ Grant No. M01 RR00034 Special Assays, Services, or TestsBionutrition and human performance laboratories: Basal or resting metabolic rate and substrate oxidation; metabolic kitchen services for feeding trials; feeding trial software (ProNutra); nutrient analysis software (Nutrition Data Systems for Research [NDS-R] and ESHA's Food Processor); food frequency questionnaires and analysis; body composition analysis with bioimpedance analysis or anthropometrics and DEXA for research fee; nutrition assessment, education, and counseling; max and sub-max exercise testing and physical activity assessment measurements and counseling; assistance with methods, protocol design, grant and paper development. Core laboratory: RIA, enzyme immunoassay (EIA), chemiluminescence, HPLC with electrochemical detection, molecular PCR with AlphaImager2000; assay determinations include: C-peptide, IGF-I, DHEA sulfate, glucose, glucagon, insulin, sex-hormone binding, growth hormone, plasma and salivary cortisol, prolactin, ACTH, plasma catecholamines, homocysteine, calcitonin, gastrin, gastrin-releasing peptide, neurotensin, pancreastatin, pancreatic polypeptide, serotonin, substance P, vasoactive intestinal polypeptide Informatics: Teleform data capture via scanning or faxing, research data mart, multicenter trial data management, computer lab Nursing services: Suction blister application for wound healing studies, chemotherapy administration, pharmacokinetic sampling, cardiac monitoring, hepatic glucose output studies, protocol-specific flowsheet design and development Major Areas of InvestigationBehavioral Psychology: Smoking cessation. Diabetes: Glucose regulation and insulin action; prevention trials of type 2 diabetes in African Americans; endocrine and metabolic responses after pancreatic transplant. Exercise Physiology: Effect of exercise on glucose metabolism in type 2 diabetics; effect of exercise on reproductive hormones; effects of programs to change physical activity in various populations. Health Psychology: Effect of stress on fatty-acid and homocysteine metabolism; effect of stress on immune, endocrine, and cardiovascular function in different populations of stressed individuals; stress and long-term survival in breast cancer patients; relaxation and wound healing studies. Hematology and Oncology: Phase I and II clinical trials. Infectious Diseases: AIDS Clinical Trials Group. Nephrology: African Americans Study of Kidney Disease (AASK); progression of renal disease; factors in the progression of autosomal dominant polycystic kidney disease. Neurology: Multiple sclerosis; Parkinson's disease. Neuromuscular Diseases: Duchenne muscular dystrophy; amyotrophic lateral sclerosis; gene therapy; limb girdle muscular dystrophy (LGMD). Nutrition: Metabolic studies; soy and/or lycopene studies; gestational and type 2 diabetes studies. Psychiatry: Drug effects in autism. Pulmonary Medicine: Emphysma lung reduction study; HIV-induced emphysema, mechanisms of lung injury. Women's Health: Risks and benefits of a number of treatments that may improve the health of postmenopausal women. Contact InformationFor information about this GCRC and how to access its resources, please contact: Administrative Director Program Director Principal Investigator Associate Program Director Associate Program Director Research Subject Advocate GCRC Advisory Committee Chairperson Director of Nursing Nurse Manager Core Laboratory Manager Bionutrition Research Manager Biostatistician Informatics Manager |
| National Institutes of Health (NIH) Bethesda, Maryland 20892 |
Department of Health and Human Services |